These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15017267)

  • 1. A new candidate vaccine for Escherichia coli pyelonephritis.
    Stapleton A
    J Urol; 2004 Apr; 171(4):1686-7. PubMed ID: 15017267
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
    Langermann S; Ballou WR
    J Infect Dis; 2001 Mar; 183 Suppl 1():S84-6. PubMed ID: 11171023
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
    J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
    Pecha B; Low D; O'Hanley P
    J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prospects for a vaccine to prevent pyelonephritis.
    Kunin CM
    N Engl J Med; 1986 Feb; 314(8):514-5. PubMed ID: 2868415
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
    Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [E. coli acute pyelonephritis: prophylaxis].
    Minodier P; Bréaud J; Bérard E
    Arch Pediatr; 2012 Nov; 19 Suppl 3():S117-23. PubMed ID: 23178132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of killed but metabolically active uropathogenic Escherichia coli strain as possible vaccine candidate for urinary tract infection.
    Jalili Z; Saleh M; Bouzari S; Pooya M
    Microb Pathog; 2018 Sep; 122():184-190. PubMed ID: 29935339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.
    Roberts JA; Kaack MB; Baskin G; Korhonen TK; Svenson SB; Winberg J
    Pediatr Nephrol; 1989 Oct; 3(4):391-6. PubMed ID: 2577147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides protect against infection in a model of experimental pyelonephritis in mice.
    Schmidt MA; O'Hanley P; Schoolnik GK
    Ann Sclavo Collana Monogr; 1986; 3(1-2):389-98. PubMed ID: 3322342
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence characteristics of Escherichia coli in acute bacterial prostatitis.
    Mitsumori K; Terai A; Yamamoto S; Ishitoya S; Yoshida O
    J Infect Dis; 1999 Oct; 180(4):1378-81. PubMed ID: 10479177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New vaccines may ward off urinary tract infections.
    Service RF
    Science; 1997 Apr; 276(5312):533. PubMed ID: 9148412
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.
    Goluszko P; Goluszko E; Nowicki B; Nowicki S; Popov V; Wang HQ
    Infect Immun; 2005 Jan; 73(1):627-31. PubMed ID: 15618205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.
    Savar NS; Jahanian-Najafabadi A; Mahdavi M; Shokrgozar MA; Jafari A; Bouzari S
    J Biotechnol; 2014 Apr; 175():31-7. PubMed ID: 24530504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental loss, but not pharmacological suppression, of renal carbonic anhydrase 2 results in pyelonephritis susceptibility.
    Ketz J; Saxena V; Arregui S; Jackson A; Schwartz GJ; Yagisawa T; Fairchild RL; Hains DS; Schwaderer AL
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1441-F1453. PubMed ID: 32390512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.